BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8050414)

  • 1. DNA damaging agents and growth factors induce changes in the program of expressed gene products through common routes.
    Blattner C; Knebel A; Radler-Pohl A; Sachsenmaier C; Herrlich P; Rahmsdorf HJ
    Environ Mol Mutagen; 1994; 24(1):3-10. PubMed ID: 8050414
    [No Abstract]   [Full Text] [Related]  

  • 2. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways.
    Blaydes JP; Craig AL; Wallace M; Ball HM; Traynor NJ; Gibbs NK; Hupp TR
    Oncogene; 2000 Aug; 19(34):3829-39. PubMed ID: 10951576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription coupled repair and its impact on mutagenesis.
    Vrieling H; van Zeeland AA; Mullenders LH
    Mutat Res; 1998 May; 400(1-2):135-42. PubMed ID: 9685614
    [No Abstract]   [Full Text] [Related]  

  • 5. The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells.
    QuiƱones A; Dobberstein KU; Rainov NG
    Life Sci; 2003 May; 72(26):2975-92. PubMed ID: 12706485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA damage-induced signal pathway of p53 as a tumor suppressor and the gene mutation in human cancer].
    Tsuchida N; Gao C; Tsuchida Y; Nakajima T; Nishigaki R
    Tanpakushitsu Kakusan Koso; 2000 Jul; 45(10):1742-51. PubMed ID: 10897687
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress.
    Amundson SA; Myers TG; Fornace AJ
    Oncogene; 1998 Dec; 17(25):3287-99. PubMed ID: 9916991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the DNA damaging potential of environmental chemicals using a quantitative high-throughput screening approach to measure p53 activation.
    Witt KL; Hsieh JH; Smith-Roe SL; Xia M; Huang R; Zhao J; Auerbach SS; Hur J; Tice RR
    Environ Mol Mutagen; 2017 Aug; 58(7):494-507. PubMed ID: 28714573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress.
    Butz K; Geisen C; Ullmann A; Zentgraf H; Hoppe-Seyler F
    Oncogene; 1998 Aug; 17(6):781-7. PubMed ID: 9715280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the p53 protein in the apoptotic response.
    Lane DP; Lu X; Hupp T; Hall PA
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):277-80. PubMed ID: 7846126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxic and non-genotoxic pathways of p53 induction.
    Pluquet O; Hainaut P
    Cancer Lett; 2001 Dec; 174(1):1-15. PubMed ID: 11675147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three distinct signalling responses by murine fibroblasts to genotoxic stress.
    Liu ZG; Baskaran R; Lea-Chou ET; Wood LD; Chen Y; Karin M; Wang JY
    Nature; 1996 Nov; 384(6606):273-6. PubMed ID: 8918879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the cell cycle structure and apoptosis of E1Aad5-immortalized rat cells after exposure to DNA damaging agents].
    Kurash IuK; Rozanov IuM; Bulavin DV; Pospelov VA; Pospelova TV
    Mol Biol (Mosk); 1998; 32(2):349-57. PubMed ID: 9608952
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage.
    Yang J; Duerksen-Hughes P
    Carcinogenesis; 1998 Jun; 19(6):1117-25. PubMed ID: 9667752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs.
    Blagosklonny MV; Robey R; Bates S; Fojo T
    J Clin Invest; 2000 Feb; 105(4):533-9. PubMed ID: 10683383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA, PANDA, Contributes to the Stabilization of p53 Tumor Suppressor Protein.
    Kotake Y; Kitagawa K; Ohhata T; Sakai S; Uchida C; Niida H; Naemura M; Kitagawa M
    Anticancer Res; 2016 Apr; 36(4):1605-11. PubMed ID: 27069137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53 stability and activity in response to genotoxic stress.
    Colman MS; Afshari CA; Barrett JC
    Mutat Res; 2000 Apr; 462(2-3):179-88. PubMed ID: 10767629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts.
    Fronza G; Inga A; Monti P; Scott G; Campomenosi P; Menichini P; Ottaggio L; Viaggi S; Burns PA; Gold B; Abbondandolo A
    Mutat Res; 2000 Apr; 462(2-3):293-301. PubMed ID: 10767639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.